Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study on Safety, Tolerability and Immunogenicity of the MVA-BN Vaccine Administered to Healthy Subjects

NCT00189943 is registered in ClinicalTrials.gov with Bavarian Nordic as lead sponsor.

NCT NCT00189943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study on Safety, Tolerability and Immunogenicity of the MVA-BN Vaccine Administered to Healthy Subjects
Lead sponsor
Bavarian Nordic
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2001
Completion date
July 31, 2003
Enrollment
90
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smallpox